388 related articles for article (PubMed ID: 37583933)
1. Hypoxia-driven ncRNAs in breast cancer.
H Al-Zuaini H; Rafiq Zahid K; Xiao X; Raza U; Huang Q; Zeng T
Front Oncol; 2023; 13():1207253. PubMed ID: 37583933
[TBL] [Abstract][Full Text] [Related]
2. Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication.
Klinge CM
Noncoding RNA; 2018 Dec; 4(4):. PubMed ID: 30545127
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs).
Dashtaki ME; Ghasemi S
Curr Mol Pharmacol; 2023; 16(8):855-869. PubMed ID: 36475334
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer.
Yi Y; Wu M; Zeng H; Hu W; Zhao C; Xiong M; Lv W; Deng P; Zhang Q; Wu Y
Front Oncol; 2021; 11():738945. PubMed ID: 34707990
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles of extracellular vesicle-associated non-coding RNAs in hypoxia: Insights from cancer, myocardial infarction and ischemic stroke.
Hermann DM; Xin W; Bähr M; Giebel B; Doeppner TR
Theranostics; 2022; 12(13):5776-5802. PubMed ID: 35966580
[TBL] [Abstract][Full Text] [Related]
6. The Roles of Hypoxia-Inducible Factors and Non-Coding RNAs in Gastrointestinal Cancer.
Cho HS; Han TS; Hur K; Ban HS
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31817259
[TBL] [Abstract][Full Text] [Related]
7. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms.
Rezaee M; Mohammadi F; Keshavarzmotamed A; Yahyazadeh S; Vakili O; Milasi YE; Veisi V; Dehmordi RM; Asadi S; Ghorbanhosseini SS; Rostami M; Alimohammadi M; Azadi A; Moussavi N; Asemi Z; Aminianfar A; Mirzaei H; Mafi A
Front Pharmacol; 2023; 14():1152672. PubMed ID: 37153758
[TBL] [Abstract][Full Text] [Related]
8. Roles and Mechanisms of Long Non-Coding RNAs in Breast Cancer.
Su J; Deng L; Wang YD
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613528
[TBL] [Abstract][Full Text] [Related]
9. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic regulation of the noncoding genome and NEAT1.
Choudhry H; Mole DR
Brief Funct Genomics; 2016 May; 15(3):174-85. PubMed ID: 26590207
[TBL] [Abstract][Full Text] [Related]
11. Recent Insights into the Angioregulatory Role of Long Non-coding RNAs and Circular RNAs in Gliomas: From Signaling Pathways to Clinical Aspects.
Hedayati N; Babaei Aghdam Z; Rezaee M; Mousavi Dehmordi R; Alimohammadi M; Mafi A
Curr Med Chem; 2024 Jan; ():. PubMed ID: 38258785
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-responsive circRNAs: A novel but important participant in non-coding RNAs ushered toward tumor hypoxia.
Jiao B; Liu S; Zhao H; Zhuang Y; Ma S; Lin C; Hu J; Liu X
Cell Death Dis; 2022 Aug; 13(8):666. PubMed ID: 35915091
[TBL] [Abstract][Full Text] [Related]
13. Targeting non-coding RNAs to overcome cancer therapy resistance.
Chen B; Dragomir MP; Yang C; Li Q; Horst D; Calin GA
Signal Transduct Target Ther; 2022 Apr; 7(1):121. PubMed ID: 35418578
[TBL] [Abstract][Full Text] [Related]
14. The Role of Hypoxia-Associated Long Non-Coding RNAs in Breast Cancer.
Maldonado V; Melendez-Zajgla J
Cells; 2022 May; 11(10):. PubMed ID: 35626715
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance.
Hashemi M; Hasani S; Hajimazdarany S; Mirmazloomi SR; Makvandy S; Zabihi A; Goldoost Y; Gholinia N; Kakavand A; Tavakolpournegari A; Salimimoghadam S; Nabavi N; Zarrabi A; Taheriazam A; Entezari M; Hushmandi K
Int J Biol Macromol; 2022 Dec; 222(Pt A):1151-1167. PubMed ID: 36191781
[TBL] [Abstract][Full Text] [Related]
16. The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer.
Liu M; Zhang S; Zhou H; Hu X; Li J; Fu B; Wei M; Huang H; Wu H
Theranostics; 2023; 13(8):2616-2631. PubMed ID: 37215575
[TBL] [Abstract][Full Text] [Related]
17. Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches.
Jesenko T; Brezar SK; Cemazar M; Biasin A; Tierno D; Scaggiante B; Grassi M; Grassi C; Dapas B; Truong NH; Abrami M; Zanconati F; Bonazza D; Rizzolio F; Parisi S; Pastorin G; Grassi G
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111734
[TBL] [Abstract][Full Text] [Related]
18. Interplay between Non-Coding RNAs and NRF2 in Different Cancers: Spotlight on MicroRNAs and Long Non-Coding RNAs.
Yaylım İ; Farooqi AA; Telkoparan-Akillilar P; Saso L
J Pharmacol Exp Ther; 2023 Jan; 384(1):28-34. PubMed ID: 35667688
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic programing of cancer stemness by transcription factors-non-coding RNAs interactions.
Alsayed RKME; Sheikhan KSAM; Alam MA; Buddenkotte J; Steinhoff M; Uddin S; Ahmad A
Semin Cancer Biol; 2023 Jul; 92():74-83. PubMed ID: 37054905
[TBL] [Abstract][Full Text] [Related]
20. A transcriptomic profile of topping responsive non-coding RNAs in tobacco roots (Nicotiana tabacum).
Chen X; Sun S; Liu F; Shen E; Liu L; Ye C; Xiao B; Timko MP; Zhu QH; Fan L; Cao P
BMC Genomics; 2019 Nov; 20(1):856. PubMed ID: 31726968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
